Top 5 Drugs Advertising in Professional Health Journals through October 2015
Print advertising dollars in professional health journals reached over $523 million through October 2015, a 3.3% increase year-over-year, according to Kantar Media.
Of the top ten products being advertised in professional health journals through October 2015, only four were on the list at this time in 2014.
Top 5 Print Ad Drugs (Dollars): YTD October 2015
- Trulicity – $8.92 MM (+17,105.1%)
- Harvoni Tablets – $8.76 MM (N/A)
- Xarelto Tablets – $8.01 MM (+44.1%)
- Invokana – $7.19 MM (-51.2%)
- Vyvanse – $6.82 MM (+207%)
The percentage changes compare January 2014–October 2014 to January–October 2015. For more information on these ad insights or other data, let us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.